secwatch / observer

8-K filed August 5, 2025, 7:59 PM ET ticker JAZZ CIK 0001232524

earnings confidence high sentiment neutral materiality 0.80

Jazz Q2 GAAP net loss $718M; revenue $1.05B up 2%; updates FY25 guidance

Jazz Pharmaceuticals plc

2025-Q2 EPS reported -$13.28 revenue$1,943,553,000

Q2 total revenues $1.05B, up 2% YoY; GAAP net loss $718.5M vs $168.6M profit in Q2 2024.
Non-GAAP adjusted net loss $504.8M vs $360.7M income; FY2025 revenue guidance revised to $4.15-$4.30B.
Xywav revenue +13% to $415.3M; added ~625 net patients in Q2, active patients ~15,225.
Renee Gala named President and CEO effective Aug 11; Bruce Cozadd becomes Chairman.
FDA Priority Review for Zepzelca combo in 1L ES-SCLC (PDUFA Oct 7); dordaviprone PDUFA Aug 18.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001232524-25-000061
form_type: 8-K
ticker: JAZZ
cik: 0001232524
company_name: Jazz Pharmaceuticals plc
filed_at: 2025-08-05T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.528965+00:00
generated_at: 2026-05-17T20:28:44.819421+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001232524-25-000061
json_url: https://secwatch.observer/filing/0001232524-25-000061.json
markdown_url: https://secwatch.observer/filing/0001232524-25-000061.md
text_url: https://secwatch.observer/filing/0001232524-25-000061.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1232524/000123252425000061/0001232524-25-000061-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1232524/000123252425000061/jazz-20250805.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

GMRS

GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B

GMR Solutions Inc. June 1, 2026, 4:45 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

HPE

HPE Q2 FY26: record revenue $10.7B (+40%), raises FY26 guidance, introduces FY27 framework

Hewlett Packard Enterprise Co June 1, 2026, 4:09 PM ET earnings Items 1.01, 2.02, 5.02, 7.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

CRDO

Credo Q4 revenue $437M (+157% YoY); guides Q1 $465-475M; CEO awarded 1.44M performance-based RSUs

Credo Technology Group Holding Ltd June 1, 2026, 4:08 PM ET earnings Items 2.02, 5.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

DAVEY TREE EXPERT CO

Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M

DAVEY TREE EXPERT CO June 1, 2026, 1:50 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

RMCF

Rocky Mountain Chocolate Factory Q4 revenue down 24% to $6.8M; net loss per share widens to $0.38

Rocky Mountain Chocolate Factory, Inc. June 1, 2026, 9:15 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

SAIC

SAIC Q1 adj EPS $3.23 beats $1.92; raises FY adj EBITDA and EPS guidance

Science Applications International Corp June 1, 2026, 6:55 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

FNGR

FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M

FingerMotion, Inc. May 29, 2026, 5:12 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

BKE

Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M

BUCKLE INC May 29, 2026, 3:38 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001232524-25-000061

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.